Pharmesis International Ltd. provided earnings guidance for the six months ended June 30, 2023. For the six months, the company expects to report a net loss for the unaudited condensed interim financial statements for the six months ended 30 June 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.12 SGD | +50.00% | +50.00% | +22.45% |
Apr. 15 | Pharmesis’ Attributable Loss for 2023 Widens | MT |
Apr. 15 | Pharmesis International Ltd. Announces the Retirement of Ms. Lin Yimin as a Director | CI |
1st Jan change | Capi. | |
---|---|---|
+22.45% | 2.43M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- BFK Stock
- News Pharmesis International Ltd.
- Pharmesis International Ltd. Provides Earnings Guidance for the Six Months Ended June 30, 2023